Regarding the secondary outcomes, patients with an abnormal AST/ALT ratio had significantly higher incidence rates of shock (32.7% vs. 3.9%, p < 0.001), acute bleeding-related anaemia (42.3% vs. 18%, p = 0.001), acute kidney failure (40.4% vs. 16.3%, p < 0.001), and cardiac arrest (28.8% vs. 7.9%, p < 0.001) than those with a normal AST/ALT ratio. The gene discussed is GPT; the disease is cardiac arrest.